End Of Exanta: AstraZeneca Drops Drug After New Report Of Liver Injury
The firm is pulling its U.S. application for the anticoagulant and will remove the drug from European markets following a report of serious liver injury.
The firm is pulling its U.S. application for the anticoagulant and will remove the drug from European markets following a report of serious liver injury.